Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/896747/000165495418005248/abmc_10q.htm
March 2023
February 2023
December 2022
June 2022
March 2022
December 2021
November 2021
October 2021
August 2021
June 2021
Document And Entity Information - shares | 3 Months Ended | |
---|---|---|
Mar. 31, 2018 | May 14, 2018 | |
Document And Entity Information [Abstract] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Period End Date | Mar. 31, 2018 | |
Document Fiscal Year Focus | 2018 | |
Document Fiscal Period Focus | Q1 | |
Entity Registrant Name | AMERICAN BIO MEDICA CORP | |
Entity Central Index Key | 0000896747 | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Smaller Reporting Company | |
Trading Symbol | ABMC | |
Entity Common Stock, Shares Outstanding | 29,932,770 |
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/896747/000165495418005248/abmc_10q.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by American Bio Medica Corp.
American Bio Medica Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
American Bio Medica Corp provided additional information to their SEC Filing as exhibits
Ticker: ABMC
CIK: 896747
Form Type: 10-Q Quarterly Report
Accession Number: 0001654954-18-005248
Submitted to the SEC: Mon May 14 2018 5:21:17 PM EST
Accepted by the SEC: Mon May 14 2018
Period: Saturday, March 31, 2018
Industry: Pharmaceutical Preparations